PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 US$
0,00%
(0,00) 1D
12. 10., 10:22:09 GMT-4 · USD
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro PTKFY…
Trž. kap.
36,51 bil.
Prům. obj.
1,96 tis.
Objem
69,00
52týd. max.
16,36 US$
52týd. min.
7,63 US$
Beta
0,09
Akcie v oběhu
234,07 mil.
Počet zaměstnanců
13 tis.
Trž. kap.
36,51 bil.
Prům. obj.
1,96 tis.
Objem
69,00
52týd. max.
16,36 US$
52týd. min.
7,63 US$
Beta
0,09
Akcie v oběhu
234,07 mil.
Počet zaměstnanců
13 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
ad-hoc-news.de
·
před 8 hodinami
Kalbe Farma launched an IDR 500 billion buyback of Kalbe Farma stock
ad-hoc-news.de
·
před 1 dnem
Kalbe Farma announced IDR 500 billion buyback of Kalbe Farma stock
ad-hoc-news.de
·
před 2 dny
Kalbe Farma stock at EUR 0.04 with IDR 34.6 trillion market cap
ad-hoc-news.de
·
před 2 dny
UBS keeps IDR 1,100 target for Kalbe Farma stock
Profil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Informace o PT Kalbe Farma Unsponsored Indonesia ADR